Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Tolerance Bio said it secured exclusive worldwide development rights and non-Japan commercialization rights for Tanabe Pharma's TLB-33, a clinical-stage anti-IL-33 monoclonal antibody. The license includes potential development and sales milestone payments of up to about $560 million, plus equity consideration and roya
For best results when printing this announcement, please click on link below: SCIEX Expands BioPhase 8800 System Capabilities to Help Laboratories Accelerate Development and Decision-making for Emerging Therapeutics SCIEX ( ), a Danaher company and leader in life science analytical technologies, today announced new cap
Moderna highlights expansion of its mRNA platform across oncology, multiple sclerosis and autoimmune diseases